Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Eurocell (ECEL) by Steve Moore in ShareProphets
- Avoid DFS Furniture (DFS) by Steve Moore in ShareProphets
- Avoid Focusrite (TUNE) by Steve Moore in ShareProphets
- Overweight Sage Group (SGE) by JP Morgan
- Sector Perform Sabre Insurance Group (SBRE) by RBC Capital
- Overweight Centrica (CNA) by JP Morgan
- Hold BP (BP.) by HSBC
- Buy Softcat (SCT) by Berenberg
- Buy Eurocell (ECEL) by Berenberg
- Buy Essentra (ESNT) by Berenberg
- Buy Rockhopper Exploration (RKH) by Canaccord Genuity
- Speculative Buy Atlantic Lithium Limited NPV (DI) (ALL) by Canaccord Genuity
- Buy YouGov (YOU) by Canaccord Genuity
- Buy Softcat (SCT) by Shore Capital
- Buy Atalaya Mining (ATYM) by Canaccord Genuity
- Buy PCI-PAL (PCIP) by Canaccord Genuity
- Buy Trainline (TRN) by Canaccord Genuity
- Hold Tinybuild Inc. (DI) (TBLD) by Shore Capital
- Buy Wickes Group (WIX) by Canaccord Genuity
- Hold Clarkson (CKN) by Canaccord Genuity
AstraZeneca (AZN) Share Price
Health Care Sector
NOTE: This is based on 1,261 open tips for AstraZeneca (AZN)
| Latest Bid : 13,926.00p | Latest Ask : 13,930.00p |
| High Today : 14,220.00p | Low Today : 13,896.00p |
| This Years High : 15,542.00p | This Years Low : 9,667.00p |
| Volume : 2,130,712 | MKT Cap : £215388M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
AstraZeneca (AZN) Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.AstraZeneca (AZN) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Jefferies | Premium Only | 2026-03-06 04:48:00 06/03/2026 | -6.79% |
| Buy | UBS | Premium Only | 2026-02-26 05:52:00 26/02/2026 | -8.24% |
| Buy | Berenberg | Premium Only | 2026-02-18 05:20:00 18/02/2026 | -10.34% |
| Add | Simon Watkins | Premium Only | 2026-02-17 08:35:00 17/02/2026 | -8.87% |
| Outperform | ODDO BHF | Premium Only | 2026-02-16 08:29:00 16/02/2026 | -7.15% |
AstraZeneca (AZN) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 13,926.00p | Latest Ask : 13,930.00p |
| High Today : 14,220.00p | Low Today : 13,896.00p |
| This Years High : 15,542.00p | This Years Low : 9,667.00p |
| Volume : 2,130,712 | MKT Cap : £215388M |
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest AstraZeneca Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Jefferies | Premium Only | 2026-03-06 04:48:00 06/03/2026 | -6.79% |
| Buy | UBS | Premium Only | 2026-02-26 05:52:00 26/02/2026 | -8.24% |
| Buy | Berenberg | Premium Only | 2026-02-18 05:20:00 18/02/2026 | -10.34% |
| Add | Simon Watkins | Premium Only | 2026-02-17 08:35:00 17/02/2026 | -8.87% |
| Outperform | ODDO BHF | Premium Only | 2026-02-16 08:29:00 16/02/2026 | -7.15% |